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Abstract
Dietary exposures implicated as reducing or causing risk for colorectal cancer may reduce or cause DNA damage in colon
tissue; however, no one has assessed this hypothesis directly in humans. Thus, we enrolled 16 healthy volunteers in a 4-
week controlled feeding study where 8 subjects were randomly assigned to dietary regimens containing meat cooked at
either low (100uC) or high temperature (250uC), each for 2 weeks in a crossover design. The other 8 subjects were randomly
assigned to dietary regimens containing the high-temperature meat diet alone or in combination with 3 putative mutagen
inhibitors: cruciferous vegetables, yogurt, and chlorophyllin tablets, also in a crossover design. Subjects were nonsmokers, at
least 18 years old, and not currently taking prescription drugs or antibiotics. We used the Salmonella assay to analyze the
meat, urine, and feces for mutagenicity, and the comet assay to analyze rectal biopsies and peripheral blood lymphocytes
for DNA damage. Low-temperature meat had undetectable levels of heterocyclic amines (HCAs) and was not mutagenic,
whereas high-temperature meat had high HCA levels and was highly mutagenic. The high-temperature meat diet increased
the mutagenicity of hydrolyzed urine and feces compared to the low-temperature meat diet. The mutagenicity of
hydrolyzed urine was increased nearly twofold by the inhibitor diet, indicating that the inhibitors enhanced conjugation.
Inhibitors decreased significantly the mutagenicity of un-hydrolyzed and hydrolyzed feces. The diets did not alter the levels
of DNA damage in non-target white blood cells, but the inhibitor diet decreased nearly twofold the DNA damage in target
colorectal cells. To our knowledge, this is the first demonstration that dietary factors can reduce DNA damage in the target
tissue of fried-meat associated carcinogenesis.
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Introduction
Colorectal cancer is the fourth most common cancer worldwide
[1], and consumption of red and processed meat has been
associated with increased risk of and mortality from this cancer
[2,3]. In particular, consumption of red meat and meat cooked at
high temperature containing elevated levels of heterocyclic amines
(HCAs) is associated with increased risk of colorectal adenoma [4].
HCAs are mutagenic and carcinogenic compounds formed
through pyrolysis of aromatic amino acids and creatinine in meats
cooked at high temperature, particularly by pan-frying [5].
Numerous studies in vitro, in animals, and in humans indicate that
various dietary components, such as cruciferous vegetables, chlor-
ophyllin (CHL), and fermented milk products, may modulate cancer
risks associated with meat consumption in general and the mutagenic
and carcinogenic effects of HCAs specifically [6–11]. Although
several small observational studies in humans [6–12] reported
protective effects of cruciferous vegetables against fried-meat-induced
PLoS ONE | www.plosone.org 1 April 2011 | Volume 6 | Issue 4 | e18707genotoxicity, epidemiologic studies [13] did not. Glucosinolates and
isothiocyanates in cruciferous vegetables inhibit HCA-induced
genotoxicity by several mechanisms, including inhibition of phase I
metabolizing enzymes, induction of phase II detoxification enzymes,
and apoptosis [6].
CHL, a copper salt derivative of chlorophyll, reduces the
mutagenicity and carcinogenicity of HCAs in vitro and in experi-
mental animals; it also reduces the genotoxic effects of aflatoxin
exposure in humans [9]. CHL forms a molecular complex with
planar carcinogens, thus inhibiting uptake in the intestine [9]; it also
exhibits antioxidant activity [14] and induces apoptosis [15].
Animal studies and small controlled feeding studies in humans
[8,16] reported that lactobacilli in fermented milk and yogurt
protect against HCA-induced genotoxicity and carcinogenicity.
Lactobacilli from dietary sources may inhibit HCA-induced
genotoxicity by binding mutagens to the bacterial cell wall or by
altered metabolism of HCAs through changes in intestinal
microflora [8].
Previous controlled feeding studies in humans focused on
changes in urinary mutagenicity after consumption of fried meat
or inhibitors of fried meat-induced mutagenesis [17]. Although
urine mutagenicity can reflect systemic exposure to dietary
mutagens and antimutagens, it does not measure the ability of
fried meat to induce DNA damage in relevant cancer-target
tissues, such as in colon epithelial cells, or the ability of putative
dietary antimutagens and anticarcinogens to reduce such damage.
To explore these issues, we used a crossover design and fed
subjects diets containing meat fried at low or high temperature
(Fig. 1) cooked as described by Sinha et al. [18]. Subjects were also
fed diets prepared with meat fried at high temperature alone or in
combination with three putative inhibitors of HCA-induced
damage (cruciferous vegetables, chlorophyllin tablets, and yogurt),
again in a crossover design. Based on the protocol of Peters et al.
[17], we evaluated the effects of the cooking methods and diets on
meat and urinary mutagenicity using the Salmonella (Ames)
mutagenicity assay, and we also extended this to fecal mutagenic-
ity. To assess the effects of the diets on target and non-target tissue,
we used the single cell gel electrophoresis (comet) assay to measure
DNA damage in epithelial cells isolated from rectal biopsies and
from lymphocytes isolated from peripheral blood. To our know-
ledge this is the first study in humans to combine measurements of
fecal and urinary mutagenicity with assessment of DNA damage in
the target tissue, colon epithelium, to evaluate the genotoxic effects
of HCAs and inhibition of that genotoxicity by dietary factors, i.e.,
cruciferous vegetables, CHL, and yogurt.
Results
Subject recruitment
Of the 70 individuals assessed for eligibility, 24 did not meet the
inclusion criteria and 30 declined to participate. Individuals were
excluded for weight (BMI.31), diet, age, underlying medical
conditions, prescription medication use, or NSAID use. Subjects
were recruited between April and August, 2004 and participated
in the study in 4 groups of 4 between June and November, 2004.
All 16 subjects enrolled in the study completed the study protocol
and results were collected and analyzed for all subjects.
Mutagenicity of meat extracts
Before the feeding study, we evaluated mutagenicity in a variety
of meats cooked at high and low temperature; results of this pilot
study (Table 1) were consistent with previous reports [17,18]. The
extract from beef cooked at low temperature was not mutagenic
and had non-detectable levels of HCAs. In contrast, the extract
from beef cooked at high temperature had high levels of HCAs,
with PhIP (2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine) be-
ing predominant, and the extract was mutagenic, exhibiting an
,10-fold higher mutagenic potency in strain YG1024 compared
to strain TA98. The results with sausage were similar to those with
high-temperature beef, and extracts from both meats were less
mutagenic in YG1041 compared to YG1024.
The extract from high-temperature bacon had extremely high
levels of HCAs and mutagenicity and was 4.5 and 7 times more
mutagenic in YG1041 and YG1024, respectively, than in TA98.
Figure 1. Study Design. Subjects were assigned randomly to arms and to treatment sequences with the restriction that each sequence included 2
men and 2 women. Diets in Arm 1 included meat cooked at low (100uC) and high temperature (250uC); diets in Arm 2 included meat cooked at high
temperature either with or without three inhibitors: cruciferous vegetables, yogurt, and chlorophyllin tablets. Subjects consumed each diet in their
assigned sequence for two-week periods. Arrows indicate sampling times for urine, stool, rectal biopsies, and leukocytes.
doi:10.1371/journal.pone.0018707.g001
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and YG1041, the presence of nitroreductase in YG1041 clearly
reduced the mutagenicity of extracts from sausage and bacon,
which likely contained nitrites that helped to form nitroarenes that
were converted to aromatic amines by nitroreductase in YG1041.
The potentially high nitrite levels in bacon may account for the
extremely high levels of mutagenicity of bacon extracts in all three
strains. Because of the potential contribution of nitrites along with
HCAs with the bacon, we decided not to include bacon in the
feeding study so that we were examining the effect of primarily
HCAs.
Mean levels of HCAs and mutagenicity of extracts from 4
batches of high-temperature beef and sausage prepared through-
out the feeding study (Table 2) were consistent with those from the
pilot, with PhIP being the predominant HCA and both extracts
exhibiting similar levels of mutagenic activity, ,10,000 rev/g in
YG1024.
Urinary mutagenicity
The estimated mutagenic potencies of extracts from un-
hydrolyzed and hydrolyzed urine from 8 subjects depended on
whether they consumed meals prepared with meat cooked at low
or high temperature (Fig. 2A). Urinary mutagenicity in un-
hydrolyzed samples increased nearly 3-fold (P=0.06), from 2.3 to
6.8 rev/mmol creatinine, respectively, from low- to high-temper-
ature meat diets. The mutagenic potency of extracts from
hydrolyzed urine increased significantly (P=0.0005) from 7.2 to
39.6 rev/mmol creatinine, respectively, from low- to high-temper-
ature meat diets. These results were consistent with the high levels
of HCAs measured in high-temperature meat.
For the 8 subjects consuming diets containing high-temperature
meat alone or in combination with the dietary inhibitors, the
mutagenic potency of extracts from un-hydrolyzed urine de-
creased slightly when subjects consumed the inhibitors (Fig. 2B). In
contrast, the mutagenic potency of extracts from hydrolyzed urine
increased nearly 2-fold, from 36.5 to 63.8 rev/mmol creatinine,
respectively, with the addition of inhibitors to the high-tempera-
ture meat diet (P=0.03).
Fecal mutagenicity
The % extractable organic matter (EOM) 6 SD for the
feces was 8.461.7 for un-hydrolyzed, 8.761.9 for hydrolyzed,
and 8.661.8 for the two combined. We saw no difference in
fecal mutagenicity in extracts from un-hydrolyzed feces be-
tween low- and high-temperature meat diets (Fig. 2C). In contrast,
extracts of hydrolyzed feces from subjects eating the high-
temperature meat diet were significantly more mutagenic
(P,0.0001) than those from subjects eating the low-temperature
meat diet, being, respectively, 33.3 versus 10.1 rev/mg of
lyophilized feces. Adding inhibitors to the high-temperature
meat diet decreased the mutagenic potencies of extracts compared
to the diet without inhibitors (Fig. 2D) from 12.3 to 4.9 rev/mg
of lyophilized feces for un-hydrolyzed feces (P=0.006) and from
40.8 to 29.3 rev/mg of lyophilized feces for hydrolyzed feces
(P=0.019).
DNA damage in colon cells and WBCs
The mean comet-assay Tail Moment (TM) of colon cells was
7.2 with low- and 8.9 with high-temperature meat, but the
increase was not statistically significant (P=0.19) (Fig. 2E–F).
When subjects consumed dietary inhibitors along with the high-
temperature meat, DNA damage in colon cells was reduced
significantly by nearly half, from a mean TM of 5.8 without
inhibitors to 3.2 with inhibitors (P=0.02). We saw no differences
among diets for DNA damage in WBCs (Fig. 2E–F).
Table 1. Estimated mutagenicity of fried meats from pilot
study.
Mutagenicity (rev/g-eq)
a
Meat Temp. TA98 YG1024 YG1041
Beef Low 8.569.5 21.0611.9 8.3614.8
High 10576307
b 100956916
b 86006169
Sausage Low Not tested Not tested Not tested
High 904681 69106194 2782661
Bacon Low Not tested Not tested Not tested
High 37596253 266496631 168776526
aUnless otherwise noted, each estimate is based on one preparation (meat
sample) assayed once; standard error reflects only variation within the plate-
incorporation assay.
bEstimate is based on three independent preparations (meat samples) each
assayed once; standard error reflects variation among samples, among assays,
and within assays.
doi:10.1371/journal.pone.0018707.t001
Table 2. Mean HCA levels and mutagenicity of low- and high-temperature-fried meats.
HCAs (ng/g) YG1024
Meat Temperature MeIQx PhIP DiMeIQx IFP (rev/g-eq)
Beef
a Low 0 0.10560.005 0 0 21.0611.9
(0.041, 0.169) (224.4, 22.4)
Sausage
a Low 0 0 0 0 Not tested
Beef
b High 10.662.6 67.3624.6 4.160.9 11.663.0 1156963625
(2.5, 18.8) (211.0, 145.7) (1.1, 7.0) (2.1, 21.1) (1503, 21635)
Sausage
b High 13.462.0 33.3611.6 4.060.7 10.562.2 1015163624
(7.1, 19.6) (23.7, 70.3) (1.8, 6.2) (3.3, 17.7) (90, 20212)
aEstimate 6 S.E. (95% confidence interval) based on 1 meat sample from the pilot study; standard errors reflect variation among duplicate assays for HCAs and variation
within a single plate-incorporation assay for mutagenicity.
bEstimate 6 S.E. (95% confidence interval) based on 4 meat samples, each assayed once from the feeding study; standard error reflects variation among samples,
among assays, and within assays.
doi:10.1371/journal.pone.0018707.t002
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PLoS ONE | www.plosone.org 3 April 2011 | Volume 6 | Issue 4 | e18707Figure 2. Dietary effects on urine and fecal mutagenicity and on DNA damage. Each arm had 8 subjects who consumed both diets in a
crossover design (Fig. 1); thus each estimate reflects data from 8 subjects. Error bars represent 95% confidence limits of the estimates calculated
through the fitted mixed-model and include subject-to-subject variation whereas P-values for diet comparisons utilize smaller within-subject
variation. Low=diet with meat fried at low temperature (100uC); High=diet with meat fried at high temperature (250uC); High+I=diet with meat
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HCAs and mutagenicity of meat extracts
In our study, high-temperature beef and sausage had HCA levels
(Table 2) comparable to those of Sinha et al. [18] who reported
concentrations of9,2.1, and 32.8 ng/g ofmeat forMeIQ(2-amino-
3,8-dimethylimidazo[4,5-f]quinoxaline), DiMeIQx (2-amino-3,4,8-
trimethylimidazo[4,5-f]quinoxaline),andPhIP,respectively.Forthe
predominant HCA, PhIP, our subjects received ,4 g of meat/kg/
day650.3 ng of PhIP/g of meat=201.2 ng of PhIP/kg/day,
corresponding to 118 ng/kg/day in Sinha et al. [18].
Based on the mutagenicity of high-temperature beef and
sausage in strain TA98 from our pilot study (Table 1), our subjects
received ,1000 rev/g of meat6,4 g/kg/day=4000 rev/kg/
day. Our subjects averaged 86 kg in weight, so a typical subject
had an intake of ,344,000 rev/day from high-temperature meat;
Peters et al. [17] reported 253,700 rev/day in a study with a
similar protocol. Extracts from fried beef and sausage were 10
times more mutagenic in YG1024 than in TA98 (Table 1),
confirming a previous study [19], and was likely due to activation
of HCAs by acetyltransferase in YG1024. When based instead on
meat-derived mutagenicity measured in strain YG1024, our
subjects had an intake of ,3,440,000 rev/day.
Effect of fried meat on urinary and fecal mutagenicity
By design this was not a metabolic study; nevertheless, we
constructed approximations to a typical subject’s output of
mutagenicity (Table 3). Because our samples include only a
portion of the urine or feces eliminated by a subject on a given
day, our approximations likely underestimate output. The increase
in HCAs in the meat was associated with a concomitant increase
in urinary mutagenicity from low- to high-temperature meat diets,
corroborating a previous finding [17] (Table 3). Unlike the
previous study [17], we used the same strain of Salmonella
(YG1024) to measure the input of meat-derived mutagenicity
and the output of urinary (and fecal) mutagenicity. Our
approximations indicate that subjects on the high-temperature
meat diet excreted 3 and 16% of ,3,440,000 rev/day intake as
unhydrolyzed and hydrolyzed urinary mutagenicity, respectively
(Table 3).
Hydrolyzed urinary mutagenicity reflects both the un-conjugated
and formerly conjugated mutagenic activity. One study [20],
however, showed an association between risk for colorectal
adenomas and unhydrolyzed urinary mutagenicity. Interestingly,
the diet with inhibitors reduced the excretion of unhydrolyzed
urinary mutagenicity by 36% (Table 3) compared to the same diet
without them, suggesting that inhibitors reduced the systemic
genotoxic exposure (i.e., unhydrolyzed urinary mutagenicity) associ-
ated with risk for colorectal adenoma. The approximations in
Table 3 indicate that without inhibitors, ,38% of the meat-derived
mutagenic intake was excreted (hydrolyzed fecal and urinary
mutagenicity combined), i.e., 509,000+787,000=1,296,000 rev/day
excreted versus 3,440,000 rev/day consumed; with inhibitors
present, this value was ,42%. We suspect that additional
mutagenic activity would have been revealed by capturing all urine
and feces excreted and by fractionating the feces [21]. There are
several classes of fecal mutagens [22], and some, such as the
fecapentanes, were not necessarily measured in our study because
they are primarily direct-acting, base-substitutionmutagens, and we
used a frameshift strain with S9 mix.
Consumption of meat fried at high temperature increased levels
of hydrolyzed fecal mutagenicity, consistent with a previous study
[21] showing that consumption of fried meat increased fecal
mutagenicity in humans. Also, fried-meat mutagens in feces were
in primarily a conjugated (or bound) form. HCAs bind to intestinal
bacteria in vitro [23], and dietary fiber (non-starch polysaccharides)
reduces HCA bioavailability in vivo [24]. Thus, meat-derived
HCAs may have been bound to dietary fiber and normal gut flora,
and their mutagenicity was revealed only when they were released
by acid hydrolysis. Because the total dietary fiber content was
approximately 38% greater with inhibitors than without them, we
cannot rule out a protective role for fiber in the inhibitor diet.
Effect of inhibitors on urinary and fecal mutagenicity
Although the diet containing inhibitors produced a non-
significant decrease in un-hydrolyzed urinary mutagenicity, it
increased hydrolyzed urinary mutagenicity nearly 2-fold (Fig. 2B).
This increase was likely due to enhanced conjugation, possibly by
components of the crucifera [6]. Cruciferous vegetables induced
the phase II enzyme NAD(P)H quinone reductase in vitro [25],
induced UDP-glucuronosyl transferase in rats [26], and increased
Table 3. Approximate output of urinary (rev/12 h) and fecal
(rev/movement) mutagenicity.
Source Study
Meat
temperature Un-hydrolyzed Hydrolyzed
Urine Peters et al.
(2004)
Low 4, 537
a 51,527
b
High 101,181
a 399,582
b
This study
c Low 32,000 101,000
High 95,000 553,000
High2inhibitors 89,000 509,000
High+inhibitors 57,000 891,000
Feces This study
d Low 163,000 196,000
High 147,000 643,000
High2inhibitors 238,000 787,000
High+inhibitors 94,000 565,000
aMean for 10 subjects.
bMean for 60 subjects.
cValues converted from mean mutagenic potencies in rev/mmole creatinine
(Fig. 2A and 2B) assuming 13964 mmole creatinine per 12 h urine sample. This
conversion factor was a median based on 36 samples (4 samples each for 8
subjects; 1 sample each for 4 subjects) of first morning voids. Although we
measured creatinine concentrations for all 64 samples (4 samples each from 16
subjects), we failed to record urine volume for 28 (4 samples each for 4
subjects plus 3 samples each for 4 subjects).
dValues converted from mean mutagenic potencies in rev/mg lyophilized feces
(Fig. 2C and 2D) assuming 19.32 g lyophilized feces per movement. This
conversion factor was a median based on 32 fecal samples (2 samples each for
16 subjects).
doi:10.1371/journal.pone.0018707.t003
fried at high temperature and inhibitors. Arm 1: Low versus High; Arm 2: High versus High+I. Panels (A) and (B): Estimated mean mutagenicity (rev/
mmole creatinine) of hydrolyzed and un-hydrolyzed urine extracts for Arm 1 and Arm 2, respectively. Mutagenicity is adjusted for the creatinine level
in each sample. Panels (C) and (D): Estimated mean mutagenicity (rev/mg lyophilized feces) of hydrolyzed and un-hydrolyzed fecal extracts for Arm 1
and Arm 2, respectively. Panels (E) and (F): Estimated mean levels of DNA damage assessed by the comet assay in WBCs and colon epithelial cells for
Arm 1 and Arm 2, respectively, based on the average across 4 slides per sample of median Tail Moment on 50 cells per slide.
doi:10.1371/journal.pone.0018707.g002
Dietary Inhibitors of Fried Meat-Induced Toxicity
PLoS ONE | www.plosone.org 5 April 2011 | Volume 6 | Issue 4 | e18707glutathione-S-transferase-a levels in human plasma and colon
epithelium [27–29].
The decrease in both hydrolyzed and un-hydrolyzed fecal
mutagenicity by the inhibitor diet (Fig. 2, Table 3) is consistent
with the binding of HCAs to CHL or to the cell walls of
lactobacilli. CHL forms molecular complexes with planar
mutagens, such as aflatoxin and HCAs, and it reduces the
mutagenicity of these compounds in Salmonella and the uptake of
these compounds in trout and rats [9]. Studies in rats suggest a
combined effect of reduced mutagen uptake and increased
conjugation by Phase II enzymes [30,31].
HCAs can bind to the cell walls of lactobacilli in vitro, decreasing
mutagenesis [23]. Lactobacilli also exhibit protective effects in
rodent and human studies, with possible mechanisms including
antioxidant activity as well as effects on cell proliferation and
apoptosis [8]. As noted earlier, the greater fiber content of our
inhibitor diet may account for some of the altered urinary and
fecal mutagenicity, as well as reduced DNA damage in colorectal
cells, produced by the inhibitor diet.
DNA damage in WBCs and rectal cells
Vegetable juices reduced DNA damage in lymphocytes in some
human dietary intervention studies [32]; however, we observed no
effects of diet on DNA damage in WBCs, although our diets did
not involve vegetable juices. In contrast, we found that diet altered
DNA damage levels in rectal cells (Fig. 2E–F). Kiss et al. [33]
showed that a fried-meat diet increased DNA damage in exfoliated
colorectal mucosal cells compared to a vegetarian diet, particularly
among subjects with GSTM1-null or NAT2-rapid genotypes. In rats,
diets containing cooked beef or chicken increased DNA single- or
double-strand breaks in colonocytes, but dietary fiber (high-
amylose maize starch) inhibited such damage [34]. Other animal
studies demonstrated the inhibition of HCA- or fried meat-
induced DNA damage by lactobacilli [8] and by cruciferous
vegetables and their constituents [26]. Given that both CHL and
compounds in cruciferous vegetables induced apoptosis in vitro
[15,35], we cannot rule out apoptosis as a mechanism for
decreased DNA damage with the inhibitor diet. To our
knowledge, this study is the first in humans to demonstrate that
dietary factors can protect rectal cells from DNA damage induced
by mutagens, such as those in fried meat.
Conclusions
Our study is limited by the small number of subjects (n=16).In
addition, we did not monitor changes in blood or urine levels of
isothiocyanates or other components of cruciferous vegetables,
CHL or chlorins, HCA-glucuronides in urine, or whether diets with
lactobacilli altered the flora in fecal samples. The study design, i.e.,
testing the effects of the three putative inhibitors together rather
than testing each inhibitor separately, prevents conclusions about
the relative importance of the three inhibitors and about their
mechanism of DNA-damage inhibition. For example, we could not
evaluate the possible interaction between the putative inhibitors,
assessing whether their protective mechanisms may have been
synergistic or antagonistic with each other. Future studies are
warranted to study the protective mechanisms of each dietary
inhibitor, cruciferous vegetables, chlorophyllin, and yogurt alone
against HCA-induced genotoxicity. Although our study was not
designed to examine differences between women and men in the
responses that we measured, a study designed to confirm whether or
not such differences exist is needed. Given the few subjects and
short-term dietary regimens, our results must be interpreted with
caution. Nevertheless, they indicate that meat cooked at high
temperature increased mutagenicity in urine and feces and that
consumption of yogurt, cruciferous vegetables, and CHL altered
urinary and fecal mutagenicity and reduced colorectal cell DNA
damage. Although increased urinary mutagenicity following
consumption of highly fried meat is well established, our study is
the first to concurrently measure both fecal mutagenicity and DNA
damage in colon epithelium and to demonstrate that dietary
antimutagens can alter these characteristics.
Materials and Methods
Study population and design
The protocol for this trial and supporting CONSORT checklist
are available as supporting information; see Checklist S1 and
Protocol S1. We conducted a randomized, controlled trial
involving 16 healthy volunteers (8 men and 8 women) recruited
by local advertisement from the Chapel Hill, NC area. Subjects
were non-smokers, aged 18–45 (mean 29.5 y), had a body mass
index ,30, and were not currently taking prescription medications
or antibiotics. Individuals were excluded if they consumed .2
alcoholic drinks/day, were vegetarians, or had a history of
diabetes, goiter, colitis, a diagnosed thyroid condition, or occult
bleeding.
Following a telephone interview to determine eligibility, we
invited individuals for a second interview. At this time, we
described the study, asked about dietary preferences, and
administered a brief questionnaire on medical and diet history
(including meat intake). Initial screening measurements for each
subject included blood pressure, body temperature, and respira-
tion rate. We recorded height and weight for diet calculations,
instructed subjects to eat only the food provided by the CTRC,
and prohibited use of aspirin, vitamins, and herbal supplements
during the study.
The study was approved by the Institutional Review Boards of
the School of Medicine at the University of North Carolina at
Chapel Hill and the National Institute of Environmental Health
Sciences, and by human studies approving officials at the U.S.
Environmental Protection Agency. All subjects provided written
informed consent.
This study had two arms, each a cross-over design (Fig. 1) that
used 8 subjects (4 men and 4 women). For each arm, 2 men and 2
women were assigned randomly to a dietary sequence consisting of
2 weeks on one defined diet followed by two weeks on another; the
remaining 4 subjects were assigned the same two diets in reverse
order. In arm 1 (Fig. 1), one diet included beef and sausage cooked
at low temperature (100uC); the other diet included the same meat
cooked at high temperature (250uC). Both contained non-
cruciferous vegetables. In arm 2 (Fig. 1), one diet included meat
cooked at high-temperature along with non-cruciferous vegetables;
the other diet included high-temperature meat along with the
putative inhibitors (cruciferous vegetables, chlorophyllin tablets,
and yogurt). Because of limited capacity at the Clinical
Translational Research Center (CTRC) at the University of
North Carolina at Chapel Hill, subjects were enrolled in groups of
4 for the 4-week protocols. At the beginning of each study period,
subjects were chosen by the study coordinator for each arm and
dietary sequence by random blind selection of lots containing
subject names from the pool of subjects available to participate in
that time period. Males and females were selected in separate
random blind lots so that assignment to dietary regimes was
balanced by gender for all arms and dietary sequences. Clinical
personnel, samples, and laboratory personnel were all blinded to a
subject’s dietary regime.
All meals were prepared at the CTRC at the University of
North Carolina at Chapel Hill. Subjects consumed breakfast and
Dietary Inhibitors of Fried Meat-Induced Toxicity
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snack.
Meat preparation and diet
Preparation of meat fried at low (100uC for 10 min/side,
followed by 20 min in an oven at 90uC to reduce moisture) and
high (250uC for 11 min/side) temperature was based on a previous
NCI study [18], with subjects consuming ,3.8–4.2 g of cooked
meat/kg body weight/day. For dietary sequences containing
putative HCA inhibitors, subjects consumed meals containing
500 g of cruciferous vegetables/day (50% cooked and 50% raw),
including green and red cabbage, broccoli, Brussels sprouts, and
cauliflower; two or three 3.3-oz containers/day based on body
weight of DanActive
TM, a probiotic cultured dairy drink
containing 10
10 CFUs of L. casei DN-114 001, S. thermophilus,
and L. bulgaricus (Dannon, White Plains, NY); and 3 100-mg
sodium copper chlorophyllin tablets/day (Derifil, Rystan Falls,
NJ). All diets were designed for weight maintenance based on
35 kcal/kg body weight and contained 20% protein, 45%
carbohydrate, and 35% fat.
Briefly, we purchased lean ground beef (15% fat, Harris Teeter,
Mathews, NC) and sausage (Wampler’s Farm Sausage, Inc. Lenoir
City, TN) locally. For high-temperature meat diets, ground beef
was cooked in 100-g patties at 250uC (482uF) on a commercial grill
(Garland, New Port Richey, FL) for 11 min on each side for a total
of 22 min then crumbled in an industrial mixer (Univex, Salem,
NH), weighed and frozen. Sausage patties (85 g) were cooked as
for ground beef and stored frozen as patties or crumbled meat. In
a pilot study, we tested the mutagenicity of bacon (Hormel
Griddlemaster, purchased locally) cooked at 250uC (482uF) for
11 min on a side. Because the mutagenicity and HCA levels for
high-temperature bacon varied significantly from those of the
high-temperature beef and sausage, we decided to use only beef
and sausage cooked at low and high temperature for the main
study. For low-temperature meat diets, beef and sausage were
cooked at 100uC (212uF) for 10 min on each side and held in a
90uC oven for 20 min to reduce moisture [18]. Subjects consumed
different amounts of meat, depending on body weight, ranging
from 211 g/day for the lightest subject (50 kg) to 343 g/day for
the heaviest subject (90 kg). The amount of high-temperature
meat consumed by each subject was calculated to approximate the
intake of HCAs/kg body weight in the previous NCI study [18].
We estimated amounts of inhibitors from previous studies; but
these amounts were designed for an overall effect and not as a
means of finding the optimal amounts for inhibition. We based the
amount of cruciferous vegetables (500 g/day) on previous studies
that showed effective reduction in urine mutagenicity and
induction of GST isoforms [12]. The amount of CHL (300 mg/
day) was a safe and effective dose based on a previous human-
intervention study [36]. These inhibitors were consumed together
with high-temperature beef and sausage. Without prior informa-
tion on levels of lactobacilli needed for inhibition of HCAs, we
arbitrarily gave subjects 2 or 3 3-oz. containers of DanActive based
on body weight; subjects weighing over 65 kg received 3
containers/day.
Body weight was measured every weekday. To minimize weight
changes, we adjusted calories for weight changes of more than
1 kg from baseline weight recorded at the start of the study. We
designed three versions of the menu for each 2-week period to
provide variety to the diet and administered them on a 3-day cycle
in both phases of the study. Nutrient values of the foods used were
based on the USDA Standard Reference nutrient database
(Number 16) and calculated using commercial software (ProNutra,
Version 3.1.0.13, Viocare Princeton, NJ).
Meat analysis
Organic extracts of fried beef and sausage were prepared and
analyzed for mutagenicity and for the following five HCAs as described
previously [37,38]: MeIQx (2-amino-3,8-dimethylimidazo[4,5-f]qui-
noxaline), 4,8-DiMeIQx (2-amino-3,4,8-trimethylimidazo[4,5-f]qui-
noxaline), 7,8-DiMeIQx (2-amino-3,7,8-trimethylimidazo[4,5-f]qui-
noxaline), PhIP (2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine),
and IFP (2-amino-(1,6-dimethylfuro[3,2-e]imidazo[4,5-b])pyridine).
Limits of detection were ,1 ng/g.
Collection of blood, rectal biopsies, urine, and stool
After consuming a dietary regimen for a full 7 days, subjects
reported each week of the 4-week study to the CTRC for a blood
draw and rectal biopsy. Subjects provided first-morning void urine
samples each day throughout the study except on Saturdays and
Sundays, and stool samples in the second and fourth weeks of the
study.
Whole blood, collected in ACD (acid dextrose citrate)
VacutainerH tubes (Becton Dickinson, Franklin Lakes, NJ), was
processed within 2 h of the blood draw for use in the comet assay.
Leukocytes were separated from whole blood using ACCUSPINH
System-HISTOPAQUEH-1077 tubes (Sigma-Aldrich, St. Louis,
MO) according to the manufacturer’s instructions.
We obtained rectal biopsies using a disposable, flexible biopsy
forceps (Boston Scientific, Natick, MA) mounted on a semi-rigid
rod and inserted through a short (25 cm), rigid, disposable
sigmoidoscope. The obdurator was removed, and the biopsy
forceps were inserted to a depth of 10 cm. We obtained at least 4
pinch biopsies from each subject each week during the study.
Biopsies were transferred from the forceps onto bibulous paper
and stored in sterile 13-ml tubes (Becton Dickinson, Franklin
Lakes, NJ) containing Hank’s Buffered Saline Solution (HBSS,
Gibco, Carlsbad, CA) with 0.3% bovine serum albumin (Gemini
Bio-Products, Sacramento, CA) and 1% penicillin (100 U/ml) and
streptomycin (0.1 mg/ml, Gibco). Samples were processed for use
in the comet assay within 2 h of the biopsy procedure.
We isolated epithelial cells from rectal biopsies using a method
described previously [39]. The 4 pinch biopsies from each subject
were pooled, minced with fine scissors, and incubated with 6 mg of
proteinase K (Invitrogen, Carlsbad, CA) and 3 mg of collagenase
(Roche, Indianapolis, IN) in 3 ml HBSS in 15-ml tubes for 30 min
in a shaker water bath at 37uC. Fresh HBSS was added to the tube
to a volume of 12 ml, and the samples were centrifuged at 1396g
for 6 min. Pellets were re-suspended in 200 ml HBSS for the comet
assay and viability testing.
Urine was first stored either on ice or at 4uC until received that
morning in the laboratory, at which time the samples were stored
at 280uC until they were processed for mutagenicity testing. We
determined the mutagenicity of organic extracts of samples
collected each week (i.e., days 7, 14, 21, and 28) after subjects
consumed a particular dietary regimen for a full 7 days. In
addition, subjects were asked to collect feces on days 14 and 28 of
the study. We recorded wet weights of the fecal samples, and
stored the samples at 280uC until processed for mutagenicity
testing.
We thawed, lyophilized, and weighed fecal samples, and then
extracted 1-g portions. For acid hydrolysis, 10 ml of 6-N HCl were
added to 1 g of lyophilized feces, the sample was mixed thoroughly
and then incubated for 6 h at 70uC. The pH was adjusted to 7.0 to
8.0, and 1 g of sodium carbonate was added as a buffer. Both
hydrolyzed and un-hydrolyzed samples were extracted twice with
dichloromethane (Burdick & Jackson, Morristown, NJ, pesticide
grade, 99.9% minimum), filtered through glass wool to remove solid
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II, Caliper Life Sciences, Hopkinton, MA), and stored at 4uC.
Comet assay
We evaluated DNA damage in white blood cells (WBCs) and
epithelial cells from rectal biopsies using a modified version of the
comet assay described previously [39]. Rectal cells were incubated
for 30 min with proteinase K and collagenase. WBCs (,10,000))
from blinded samples in 10 ml phosphate-buffered saline (PBS,
Gibco, Carlsbad, CA) or rectal biopsy cells (,50,000) in 10 ml
Hank’s Buffered Saline Solution (HBSS, Gibco, Carlsbad, CA)
were suspended in 100 ml of 1% (w/v) low-melting point agarose
in PBS, pH 7.4 at 37uC, and pipetted immediately onto slides pre-
coated with 1% (w/v) normal-melting point agarose. After a
second layer of 100 ml of low-melting point agarose was pipetted
on top of the previous layer, slides were allowed to cool for
,10 min at 4uC and immersed in lysis solution (2.5-M NaCl,
100-mM Na2EDTA, 10-mM Tris, 1% (v/v) Triton-X 100, and
NaOH at pH 13.0) at 4uC overnight. Following cell lysis, slides
were neutralized for 5 min in 0.4-M Tris-HCl, pH 7.5 and then
placed in a horizontal electrophoresis tank containing 0.3-M
NaOH and 1-mM Na2EDTA, pH 13 to unwind the DNA for
40 min followed by electrophoresis at a constant voltage of 25 V
for 40 min. We used these relatively long unwinding and
electrophoresis times to detect the basal levels of damage
associated with the different diets and to increase our ability to
detect any protective effects of the inhibitor diet. Slides were
washed 3 times for 5 min each with 0.4-M Tris-HCl, pH 7.5,
placed in cold EtOH, dried, and stained with 20 mg/ml of ethidium
bromide. We scored50 comets/slideand 4 slides/sample, for a total
of 200 cells/sample, using Komet 5.0 software (Kinetic Imaging
Ltd., Liverpool, UK). We performed all experiments in low light to
reduce background UV induction of DNA damage. We scored and
expressed the results as Tail Moment (TM). Viability of leukocytes
and rectal biopsy cells was determined as described [40] and was
.80%.
Mutagenicity assays
We evaluated fried meat extracts for mutagenicity in the
Salmonella plate-incorporation assay [41] in the frameshift strain
TA98 [hisD3052 chl-1008 (bio uvrB gal) rfa-1004 pKM101
+ Fels-1
+
Fels-2
+ Gifsy-1
+ Gifsy-2
+] and two of its derivatives, YG1024 and
YG1041. Strain YG1024 expresses acetyltransferase, which
activates HCAs to mutagens [42], and YG1041 expresses both
acetyltransferase and nitroreductase, which activates nitroarenes
to mutagens [43]. Urine and stool extracts were tested only in
YG1024. All extracts were tested in the presence of Arochlor-
induced rat liver S-9 (Moltox, Boone, NC) at 2 mg of S9 protein/
plate in one or two plates per dose, depending on the sample
availability. Meat extracts were tested at a dose range of 0.06 to
1.25 g-eq/plate.
Organic extracts of urine were prepared in a manner similar
that described previously [12,17]. Briefly, 25–30 ml of urine were
hydrolyzed in 6-N HCl for 6 h at 70uC. The hydrolysate and a
similar portion of unhydrolyzed urine were extracted by C18/
methanol, the extract was solvent-exchanged into DMSO at
1506, and the concentrate was frozen until tested for mutagenicity
at 0.3 to 6.0 ml-eq/plate. We used acid hydrolysis because, as
noted in our earlier studies [12,17], acid hydrolysis is a highly
effective method to deconjugate HCAs in urine. Doses were
converted from ml-eq/plate to mmoles of creatinine/plate as
described in the Supporting information (File S1, Table S5).
Fecal samples were lyophilized and weighed, a portion was
hydrolyzed for 6 h at 70uC in 6-N HCl, the pH was adjusted to 7.0
to 8.0, and the sample was extracted twice with dichloromethane.
The percent extractable organic matter (EOM) was determined by
standard methods [44], and extracts were tested for mutagenicity
at 40 to 400 mg of EOM/plate. In order to assess the mutagenic
activity of the feces in a manner similar to that of the urine, we also
used acid hydrolysis with the feces. Doses were converted from mg
of EOM/plate to mg of lyophilized feces/plate as described in the
Supporting information (File S1, Table S9).
Statistical analyses
Levels of HCAs in meat. We computed means, standard
deviations, and 95% confidence limits for HCA levels using data
from 4 independent preparations each of beef and sausage cooked
at high temperature.
Estimation of mutagenic potency: general consi-
derations. The data from a single plate-incorporation assay
consist of counts of mutant colonies from one or more plates at
each in a series of increasing concentrations (doses) of the extract
under test. The underlying theory holds that the mutagenic
potency of the extract is the slope of the linear portion of the
resulting dose-response relationship. Consequently, because
toxicity may cause the dose-response trajectory to flatten or turn
down at high doses, we followed toxicologic practice in allowing
only doses deemed within the linear range to contribute to
estimation [41]. In the Supporting Information (File S1), we
provide dose-specific average counts for every assay that we
conducted.
Let E(Yd) denote the expected (mean) number of mutant
colonies at dose d. For estimating mutagenic potency based on a
single assay, we modeled the expected counts as a linear function
of dose, namely, E(Yd)~azbd where a, the expected count at
dose 0, reflects the background mutant yield in the Salmonella strain
used in the assay and b, the slope, is the mutagenic potency. We
regarded plate counts as Poisson distributed but allowed for over-
dispersion among plates within an assay. This model is a
generalized linear model (GLM) with a Poisson error distribution,
the identity link function, and over-dispersion parameter [45]. We
fit such GLMs using PROC GENMOD in SAS version 9.1 (SAS
Institute, Cary, NC).
For estimating mutagenic potency when multiple specimens or
multiple assays per specimen contributed to a common average
mutagenic potency, we used closely related but more elaborate
models that reflected sources of variation in the data and
assumptions about assay properties. If we assayed multiple
specimens (from the same or different treatments) on the same
day, their assays all shared the same dose 0 plate(s), reflecting that
the background mutant yield is regarded as the same for all
specimens on a given day; however, separate dose 0 plates were run
on different days, reflecting that uncontrolled day-to- day
fluctuations in the laboratory environment could induce minor
day-to-day disturbances in the background mutant yield. Similarly,
we expected mutagenic potency to vary slightly from assay to assay
if, for example, a given specimen was assayed on multiple days or if
different specimens representing a given treatment were assayed on
the same day. To reflect such sources of extra-Poisson variation, we
used generalized linear mixed models (GLMMs) [46]. As a simple
example, consider that we assayed a separate preparation of beef
cooked at high temperature on each of 3 days in strain YG1024.
Our statistical analysis was based on the following model:
E(Yid u j i)~ azua
i

z bzu
b
i

d: ð1Þ
Here, a and b havethe same interpretations as earlier, i[f1,2,3g
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b
i
represent disturbances on day i to the intercept and to the
mutagenic potency, respectively, attributable to random day-to-day
variation among assays, and E(Yid u j i) represents the expected
number of mutant colonies at dose d on day i conditional on the
values of the disturbances. As before, we regarded plate counts as
Poisson distributed; in addition, the disturbances ua
i and u
b
i (termed
‘randomeffects’)weremodeled asindependentmean-zeroGaussian
random variables, each with its own variance. We modeled over-
dispersion through a residual error variance. We fit such GLMMs
using the SAS GLIMMIX macro [47].
We applied GLMMs more elaborate than model (1) as the
experiment’s design required. If an analysis involved estimation of
mutagenic potencies for more than one treatment, model (1) was
extended to include additional slopes (b-terms) to estimate
mutagenic potency for each treatment. In addition, analyses for
more complicated designs, like our crossover designs, involved
additional possible random disturbances to each slope, that is,
additional terms analogous to u
b
i in model (1). For crossover
designs, we also considered carryover [48] from the diet given in
one period onto the diet given in the following period to influence
slopes. Because specimen-to-specimen or assay-to-assay variation
in mutagenic potency tends to be larger for treatments with higher
mutagenic potency, our models incorporated heterogeneity of
variances across treatments for certain random effects. To choose
a parsimonious specification for modeling the random effects in a
GLMM, we used BIC [49], a widely used model-selection
criterion. Also, we checked that the estimated random effects
obeyed the Gaussian distribution assumption. In the following
subsections, we indicate when we used additional slopes, what
random effects were modeled for slopes, and whether the models
involved heterogeneous variances. All our GLMMs, like model (1),
modeled only day as having a random effect on the intercept.
Estimation of mutagenic potency: meat extracts. Our
pilot study assayed three types of meat (bacon, beef, sausage)
cooked at two temperatures (low, high) in three different strains of
Salmonella (TA98, YG1024, YG1041). Each assay involved one or
two plates (depending on specimen volume available) at each of 6
doses (g-eq/plate), including zero. We estimated the mean
mutagenic potency and its standard error for each treatment
combination of type, temperature, and strain by fitting a separate
model for each treatment combination. Treatment combinations
that involved a single meat preparation assayed once were
analyzed using a GLM. Two treatment combinations (Table 1),
however, involved three independent meat preparations, each
assayed on a separate day, and were analyzed using the GLMM of
model (1), which included a random effect of day on mutagenic
potency.
During the feeding study, we used strain YG1024 to monitor the
mutagenic potency of two types of meat (beef, sausage) cooked at
high temperature, each type represented by 4 independent
preparations. Assays were conducted on three separate days (one
beef and one sausage preparation each on two days; two beef and
two sausagepreparationsonthethird).Eachassayusedoneplateper
dose level. On each day, we used a single zero-dose plate for both
typesofmeatand,therefore,analyzedbothtypesinasinglestatistical
analysis with a GLMM. We modeled expected plate counts as two
lines with a common intercept but separate slopes for beef and
sausage. We included random effects on mutagenic potencies (meat-
type-specific slopes) for days and for preparations within days.
Estimation of mutagenic potency: urine. We collected
urine specimens from every subject in every period of the crossover
design (Fig. 1) (though one specimen had sufficient volume for only
an unhydrolyzed sub-sample) and conducted assays on 4 days for
arm-1 samples and 4 days for arm-2 samples. On each day, one set
of 3 or 6 zero dose plates was used for all assays. Each specimen,
including both the hydrolyzed and unhydrolyzed sub-samples, was
assayed on only one day. Each assay involved 4–5 non-zero doses
(mmole creatinine) with one plate per dose. We analyzed data from
each arm separately with the same method of analysis. We
estimated mutagenic potencies and their standard errors for each
diet with both hydrolyzed and unhydrolyzed extracts (4 potency
estimates per arm); we also tested for differences in mutagenic
potency between diets separately for hydrolyzed and for
unhydrolyzed extracts.
For each arm, we analyzed data on diet and acid hydrolysis
treatment together using a GLMM. We modeled the expected
plate counts as 4 lines with a common intercept and 4 separate
slopes, one for each combination of diet and hydrolysis treatment;
we also allowed for possible carryover effects on slopes. The
GLMM included random effects of subjects, periods, specimens,
sub-samples on the slopes as well as residual variation. We
accommodated variance heterogeneity by allowing the variances
of random effects for specimens, sub-samples, and residual
variation to depend on treatment combination. The estimated
mutagenic potencies that we report are adjusted for carryover
effects through the fitted model.
Estimation of mutagenic potency: feces. The crossover
design for fecal specimens involved two periods (Fig. 1); we
collected a specimen from every subject in each period. Each
specimen was represented by a hydrolyzed and an un-hydrolyzed
sub-sample. Plate-incorporation assays were conducted on 7 days
for arm-1 and 3 days for arm-2 specimens. On each day, all
specimens were represented by 2 or 3 zero-dose plates. Each
specimen, including both sub-samples, was assayed on three
distinct days (replicate assays). Each replicate assay involved 4–5
non-zero doses (mg lyophilized feces) with 1 or 2 plates per dose,
depending on available specimen volume.
We analyzed each arm of the study separately using the same
GLMM. As with urine, we modeled the expected plate counts as 4
lines with a common intercept and 4 separate slopes, one for each
combination of diet and hydrolysis treatment; we also allowed for
possible carryover effects on slopes. The GLMM for feces differed
from that for urine in accommodating replicate assays of the same
sub-samples. It included random effects of subjects, periods,
specimens, and replicate assays on the slopes as well residual
variation and allowed the variances of random effects for
specimens, assays, and residual variation to depend on treatment
combination. The estimated mutagenic potencies that we report
are adjusted for carryover effects through the fitted model.
Estimation of DNA damage in leukocytes and colon
epithelium cells. We had both leukocyte (WBC) samples and
rectal epithelium biopsy specimens from every subject each week
during each arm of our crossover study (Fig. 1). All specimens
(WBCs and rectal cells) were evaluated by the comet assay on the
day that they were collected. For each specimen, we computed
median TM values from the comet assay across 50 cells per slide
and averaged these medians across 4 slides; thus, our DNA-
damage measure represented a typical value among 200 cells per
specimen. We analyzed DNA damage in each arm and in
leukocytes and rectal epithelium separately, four analyses in all.
We employed mixed-model analysis-of-variance techniques
appropriate for our crossover design [48] using PROC
MIXED
TM in SAS 9.1. In each arm, after verifying that
carryover effects were unimportant (p.0.25), we estimated the
mean response for each diet using a model that included random
effects of subject, period, and residual error. We report model-
based estimates and confidence limits for mean TM for each diet.
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